Your browser doesn't support javascript.
loading
What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?
Barrau, Mathilde; Roblin, Xavier; Andromaque, Leslie; Rozieres, Aurore; Faure, Mathias; Paul, Stéphane; Nancey, Stéphane.
Afiliação
  • Barrau M; Department of Gastroenterology, University Hospital of Saint-Etienne, 42000 Saint-Etienne, France.
  • Roblin X; Department of Gastroenterology, University Hospital of Saint-Etienne, 42000 Saint-Etienne, France.
  • Andromaque L; CIRI-Centre International de Recherche en Infectiologie, University Lyon, Inserm U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.
  • Rozieres A; CIRI-Centre International de Recherche en Infectiologie, University Lyon, Inserm U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.
  • Faure M; CIRI-Centre International de Recherche en Infectiologie, University Lyon, Inserm U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.
  • Paul S; Department of Immunology, CIC1408, GIMAP EA3064, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France.
  • Nancey S; CIRI-Centre International de Recherche en Infectiologie, University Lyon, Inserm U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.
J Clin Med ; 12(23)2023 Dec 04.
Article em En | MEDLINE | ID: mdl-38068547

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França